Status:
COMPLETED
Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Healthy
Type 2 Diabetes
Eligibility:
MALE
25-80 years
Phase:
NA
Brief Summary
The aim of the present protocol is to study gene activity in fat and muscle tissue in type 2 diabetics and healthy volunteers after injection of E. coli endotoxin.We hereby hope to gain insight in som...
Detailed Description
Numerous studies have shown an association between low-grade inflammation and insulin-resistance in type 2 diabetics. It is also well-known that septic patients often develop insulin-resistance. The p...
Eligibility Criteria
Inclusion
- Healthy
- Type 2 diabetes
Exclusion
- Heart failure
- Lung disease
- Anti-coagulation treatment
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2008
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00412906
Start Date
November 1 2006
End Date
April 1 2008
Last Update
May 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Inflammaiton and Metabolism, Rigshospitalet
Copenhagen, Denmark, 2100